Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above

PHASE3

Phase

COMPLETED

Status

150

Enrollment

OTHER_GOV

Sponsor class

Conditions

BIOLOGICAL: EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)

Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"